Valantine Hannah (CIK 1855608) reported 32 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-07-17). Recent activity: Buy CDNA (7,606 shares), Buy CDNA (16,048 shares), Buy CDNA (5,125 shares), Sell CDNA (28,679 shares), Sell CDNA (100 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-17 | CareDx, Inc. (CDNA) | Director | Buy | 7,606 | $156,379 |
| 2026-07-17 | CareDx, Inc. (CDNA) | Director | Buy | 16,048 | $227,721 |
| 2026-07-17 | CareDx, Inc. (CDNA) | Director | Buy | 5,125 | $40,795 |
| 2026-07-17 | CareDx, Inc. (CDNA) | Director | Sell | 28,679 | $1.0M |
| 2026-07-17 | CareDx, Inc. (CDNA) | Director | Sell | 100 | $3,655 |
| 2026-06-24 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 3,990 | $0 |
| 2026-06-24 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 2,808 | $117,178 |
| 2026-06-24 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 2,808 | $190,944 |
| 2026-06-24 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 2,196 | $150,580 |
| 2026-06-16 | CareDx, Inc. (CDNA) | Director | Buy | 9,795 | $0 |
| 2026-06-16 | CareDx, Inc. (CDNA) | Director | Sell | 12,103 | $279,728 |
| 2026-03-12 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 8,671 | $624,312 |
| 2026-03-12 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 8,671 | $237,239 |
| 2026-03-03 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 25,484 | $1.2M |
| 2026-03-03 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 14,584 | $978,295 |
| 2026-03-03 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 10,900 | $739,456 |
| 2025-11-14 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 25,484 | $1.2M |
| 2025-11-14 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 25,484 | $1.7M |
| 2025-06-30 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 1,542 | $19,553 |
| 2025-06-30 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 796 | $10,475 |
| 2025-06-30 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 876 | $38,640 |
| 2025-06-30 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 1,542 | $67,863 |
| 2025-06-30 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 398 | $17,564 |
| 2025-06-30 | BridgeBio Pharma, Inc. (BBIO) | Director | Sell | 1,891 | $83,261 |
| 2025-06-30 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 1,752 | $24,948 |
Source: SEC Form 4 filings · as of 2026-07-17